
Microba
MAP.AXMicroba Life Sciences Limited Price (MAP.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
409,858,784
(23.0844)%
Cash Flow Statement
Microba Life Sciences LimitedCurrency: AUD
YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||||||
Net Income | -4,733,829.00
+0% |
-6,650,667.00
+40% |
-7,523,752.00
+13% |
-11,470,429.00
+52% |
-12,680,212.00
+11% |
-19,938,485.00
+57% |
|||||||||||||
Depreciation And Amortiz... | 765.18k | 1.09M | 1.22M | 1.54M | 1.64M | 0.00 | |||||||||||||
Deferred Income Tax | 12.97k | -6,520.00 | -3,743,994.00 | -3,972,968.00 | -5,696,494.00 | 0.00 | |||||||||||||
Stock-Based Compensat... | 182.87k | 467.39k | 562.79k | 641.57k | 420.99k | 0.00 | |||||||||||||
Change In Working Capital | |||||||||||||||||||
Accounts Receivables | 245.35k | -460,441.00 | -1,027,131.00 | -1,772,600.00 | -3,813,682.00 | 0.00 | |||||||||||||
Accounts Payables | 336.46k | 547.77k | 454.56k | 1.37M | 2.11M | 208.53k | |||||||||||||
Inventory | -163,841.00 | -171,209.00 | -172,472.00 | 153.25k | -284,394.00 | 0.00 | |||||||||||||
Other Working Capital | -296,690.00 | 885.40k | -543,177.00 | -7,069.00 | 372.43k | 1.10M | |||||||||||||
Other Non-Cash Items | 1.33M | 2.71M | 3.59M | 3.06M | 5.54M | 4.37M | |||||||||||||
Net Cash Provided By Op... | -3,620,558.00
+0% |
-4,323,278.00
+19% |
-7,181,584.00
+66% |
-10,448,812.00
+45% |
-12,393,828.00
+19% |
-15,566,936.00
+26% |
|||||||||||||
Investing Activities | |||||||||||||||||||
Investments In Propert... | -836,127.00 | -856,175.00 | -672,455.00 | -1,872,764.00 | -3,036,890.00 | -1,487,327.00 | |||||||||||||
Acquisitions Net | 2.42k | 0.00 | 0.00 | 8.75k | 0.00 | -9,570,127.00 | |||||||||||||
Purchases Of Investments | 0.00 | 0.00 | 0.00 | -154,134.00 | 0.00 | 0.00 | |||||||||||||
Sales Maturities Of Inve... | 0.00 | 0.00 | 0.00 | 227.95k | 0.00 | 0.00 | |||||||||||||
Other Investing Activities | -701,952.00 | -495,316.00 | 149.97k | 57.84k | 38.09k | -2,891,726.00 | |||||||||||||
Net Cash Used For Inv... | -833,705.00
+0% |
-856,175.00
+3% |
-522,483.00
-39% |
-1,732,354.00
+232% |
-2,998,803.00
+73% |
-13,949,180.00
+365% |
|||||||||||||
Financing Activities | |||||||||||||||||||
Debt Repayment | -144,782.00 | -125,190.00 | -141,333.00 | 201.59k | -5,337.00 | 59.90k | |||||||||||||
Common Stock Issued | 10.56M | 1.40M | 14.19M | 31.25M | 17.24M | 20.36M | |||||||||||||
Common Stock Repurch... | 0.00 | 0.00 | 0.00 | -1,904,955.00 | -595,626.00 | -1,257,344.00 | |||||||||||||
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Other Financing Activities | 3.30M | -193,352.00 | -216,671.00 | -330,835.00 | -547,837.00 | -765,091.00 | |||||||||||||
Net Cash Used/Provide... | 13.72M
+0% |
1.08M
-92% |
13.84M
+1,179% |
29.22M
+111% |
16.68M
-43% |
18.39M
+10% |
|||||||||||||
Effect Of Forex Changes... | 1.73M | 0.00 | -50,302.00 | 567.43k | 171.36k | -32,488.00 | |||||||||||||
Net Change In Cash | 11.00M | -4,097,995.00 | 6.13M | 17.60M | 1.26M | -11,154,423.00 | |||||||||||||
Cash At Beginning Of Per... | 0.00 | 11.00M | 6.90M | 12.98M | 30.79M | 32.04M | |||||||||||||
Cash At End Of Period | 11.00M | 6.90M | 13.03M | 30.58M | 32.04M | 20.89M | |||||||||||||
Additional Metrics: | |||||||||||||||||||
Operating Cash Flow | -3,620,558.00 | -4,323,278.00 | -7,181,584.00 | -10,448,812.00 | -12,393,828.00 | -15,566,936.00 | |||||||||||||
Capital Expenditure | -836,127.00 | -856,175.00 | -672,455.00 | -1,872,764.00 | -3,036,890.00 | -4,379,053.00 | |||||||||||||
Free Cash Flow | -4,456,685.00
+0% |
-5,179,453.00
+16% |
-7,854,039.00
+52% |
-12,321,576.00
+57% |
-15,430,718.00
+25% |
-19,945,989.00
+29% |